×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [5]
Authors
XIANG YUTAO [5]
YUAN ZHEN [1]
Document Type
Journal article [5]
Conference paper [1]
Date Issued
2019 [2]
2018 [2]
2016 [2]
Language
英語English [6]
Source Publication
Epidemiology and... [2]
ACTA PSYCHIATRIC... [1]
DIABETIC MEDICIN... [1]
Psychological Me... [1]
Indexed By
SCIE [6]
SSCI [5]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-6 of 6
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Suicide-related behaviours in schizophrenia in China: A comprehensive meta-analysis
Journal article
Dong,M., Wang,S. B., Wang,F., Zhang,L., Ungvari,G. S., Ng,C. H., Meng,X., Yuan,Z., Wang,G., Xiang,Y. T.. Suicide-related behaviours in schizophrenia in China: A comprehensive meta-analysis[J]. Epidemiology and Psychiatric Sciences, 2019, 28(3), 290-299.
Authors:
Dong,M.
;
Wang,S. B.
;
Wang,F.
;
Zhang,L.
;
Ungvari,G. S.
; et al.
Favorite
|
TC[WOS]:
18
TC[Scopus]:
18
IF:
5.9
/
7.3
|
Submit date:2021/03/02
China
Meta-analysis
Schizophrenia
Suicide
Prevalence of comorbid major depressive disorder in Type 2 diabetes: a meta-analysis of comparative and epidemiological studies
Journal article
F. Wang, S. Wang, Q.-Q. Zong, Q. Zhang, C.H.Ng, G. S. Ungvari, Y.-T. Xiang. Prevalence of comorbid major depressive disorder in Type 2 diabetes: a meta-analysis of comparative and epidemiological studies[J]. DIABETIC MEDICINE, 2019, 36(8), 961-969.
Authors:
F. Wang
;
S. Wang
;
Q.-Q. Zong
;
Q. Zhang
;
C.H.Ng
; et al.
Favorite
|
TC[WOS]:
57
TC[Scopus]:
59
IF:
3.2
/
4.0
|
Submit date:2021/03/02
Relationship of sleep duration with demographics, lifestyle, mental health, and chronic diseases
Conference paper
Ng, C. H., Wang, S. B., Li, B., Wu, Y. H., Ungvari, G. S., Fu, Y. L., Kou, C. G., Yu, Y. Q., Sun, H. Q., Xiang, Y. T.. Relationship of sleep duration with demographics, lifestyle, mental health, and chronic diseases[C], THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND:PERGAMON-ELSEVIER SCIENCE LTD, 2018, 122-122.
Authors:
Ng, C. H.
;
Wang, S. B.
;
Li, B.
;
Wu, Y. H.
;
Ungvari, G. S.
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2018/10/30
N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials
Journal article
Zheng, W., Zhang, Q. -E., Cai, D. -B., Yang, X. -H., Qiu, Y., Ungvari, G. S., Ng, C. H., Berk, M., Ning, Y. -P., Xiang, Y. -T.. N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials[J]. ACTA PSYCHIATRICA SCANDINAVICA, 2018, 137(5), 391-400.
Authors:
Zheng, W.
;
Zhang, Q. -E.
;
Cai, D. -B.
;
Yang, X. -H.
;
Qiu, Y.
; et al.
Favorite
|
TC[WOS]:
65
TC[Scopus]:
67
IF:
5.3
/
6.6
|
Submit date:2018/10/30
N-acetylcysteine
Oxidative Stress
Schizophrenia
Bipolar Disorder
Major Depressive Disorder
Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia
Journal article
Y.-T. Xiang, G. S. Ungvari, C. U. Correll, H. F. K. Chiu, N. Shinfuku. Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia[J]. Epidemiology and Psychiatric Sciences, 2016, 25(1), 9-17.
Authors:
Y.-T. Xiang
;
G. S. Ungvari
;
C. U. Correll
;
H. F. K. Chiu
;
N. Shinfuku
Favorite
|
TC[WOS]:
18
TC[Scopus]:
18
IF:
5.9
/
7.3
|
Submit date:2019/01/07
Asia
Schizophrenia
Prescription Patterns
Psychotropic Medications
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: Results from a randomized, placebo-controlled 4-week study
Journal article
Hu Y.-D., Xiang Y.-T., Fang J.-X., Zu S., Sha S., Shi H., Ungvari G.S., Correll C.U., Chiu H.F.K., Xue Y., Tian T.-F., Wu A.-S., Ma X., Wang G.. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: Results from a randomized, placebo-controlled 4-week study[J]. Psychological Medicine, 2016, 46(3), 623.
Authors:
Hu Y.-D.
;
Xiang Y.-T.
;
Fang J.-X.
;
Zu S.
;
Sha S.
; et al.
Favorite
|
TC[WOS]:
109
TC[Scopus]:
117
|
Submit date:2018/10/30
Escitalopram
Ketamine
Key Words Efficacy
Major Depression
Response
Tolerability